A detailed history of Qrg Capital Management, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Qrg Capital Management, Inc. holds 134,816 shares of VCYT stock, worth $4.95 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
134,816
Previous 129,416 4.17%
Holding current value
$4.95 Million
Previous $2.8 Billion 63.64%
% of portfolio
0.05%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$21.0 - $35.25 $113,400 - $190,350
5,400 Added 4.17%
134,816 $4.59 Billion
Q2 2024

Jul 12, 2024

BUY
$18.86 - $23.55 $75,722 - $94,553
4,015 Added 3.2%
129,416 $2.8 Billion
Q1 2024

May 07, 2024

SELL
$21.0 - $29.1 $178,164 - $246,884
-8,484 Reduced 6.34%
125,401 $2.78 Billion
Q4 2023

Feb 07, 2024

BUY
$19.72 - $28.68 $129,816 - $188,800
6,583 Added 5.17%
133,885 $3.68 Billion
Q3 2023

Nov 13, 2023

BUY
$22.33 - $29.92 $2.84 Million - $3.81 Million
127,302 New
127,302 $2.84 Billion

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.63B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Qrg Capital Management, Inc. Portfolio

Follow Qrg Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qrg Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Qrg Capital Management, Inc. with notifications on news.